CANCER
Characterized by uncontrolled
cell proliferation
Arises from irreversible genetic
damage to cells DNA, block in
normal process of
differentiation, or block in
apoptosis
Term cancer : Hippocrates (400
BC)
Observation: Veins radiating
Introduction to Genes:
Genes are carried on chromosomes and are the
basic physical and functional units of heredity .
A genome is the full set of genes in each cell
of an organism.
Form the basic unit of heredity and Encode how
to make a protein.
i.e. DNARNA proteins
Proteins carry out most of lifes function and if
altered causes a number of diseases.
When genes are altered so that the encoded
proteins are unable to carry out their normal
G0
Mitosis
1 hour of 16 hour
cell cycle
(resting phase)
DNA synthesis
2.
Progressive
Acquisition of
Neoplastic Features
Apoptosis downregulation
Lack of response
to inhibitory
factors
Self-sustained
proliferation
Apoptosis
downregulation
Telomerase
reactivation
Cooperative
genetic
damage
Mutagenic
agents
Defective
repair systems
Hypotheses of the
Origin of
Neoplasia
1. Oncogenes and Tumor Suppressor
Genes
2. Viral Oncogene Hypothesis
3. Epigenetic Hypothesis
4. Failure of Immune Surveillance
Origin of Neoplasia
two general types
Monoclonal
Initial neoplastic change affects a
single cell
Field origin
Carcinogen acts on large number
of cells producing field of
potentially neoplastic cells
Alterations of Specific
CellularDNA
Functions
in
Repair
Cancer
Tumor Suppressor
Oncogenes
Genes
Activation
Inactivation
Proliferation
CANCER
Types Of Oncogenes
Two main types :
Viral oncogene: gene from the
retrovirus itself
Non-Viral oncogene (Cellular
oncogene): genes derived from the
genes of the host cell that are in an
inactive form usually. Occasionally if
the gene incorporates with the viral
genome will form a highly oncogenic
virus.
Functions Of Proto-oncogenes
Oncogenes/Proto-oncogenes
2) Viral Oncogene
Hypothesis
RNA Retrovirus produces DNA
provirus
DNA provirus containing viral
oncogene (v-onc) is introduced, or
DNA provirus without v-onc is
inserted adjacent to c-onc in host
cell DNA
RNA viruses is thought to have
acquired v-onc sequence by
recombinant mechanism from
animal cells
DNA virus
SIGNAL
TRANSDUCTION
PATHWAY AS A
SOURCE OF
PROTOONCOGENES
Ras
Growth
Pathway
factor binds
receptor
Receptor
exchanges
GTP for GDP
on Ras
Ras
activated
RasRafM
MECHANISMS OF
CONVERSION OF
PROTOONCOGENE INTO
ONCOGENE
1) Point Mutation
2)Gene Amplification
How Cellular
Oncogenes Arise
35
3)Chromosomal Translocation
5)Insertional Mutagenesis
Occurs during viral DNA integration
Eg: Avian leukosis virus- integrate
within c-myc oncogene
Exon 1-unknown function
Exon 2 & 3 encode MYC protein
ALV integrates between exon 1 & 2
OR
Inactivated
Categories of tumor
suppressor genes
Caretaker genes:
Maintain the integrity of the genome
by repairing DNA damage
Gatekeeper genes:
Inhibit the proliferation or promote
the death of cells with damaged DNA
Function
Tumor
susceptibility if
germ line
mutation
Comments
Gatekeep p53
ers
Transcription
factor
Li-Fraumeni
syndrome
Also mutated in
>50% of human
cancers
Rb1
Transcription
al regulator
Familial
retinoblastoma
Often mutated in
other cancers
APC
Regulates catenin
function
Familial
adenomatus
polyposis
Often mutated in
sporadic
colorectal cancers
BRCA
1
DNA repair
Breast and
ovarian cancer
Rarely mutated in
sporadic breast
cancers
BRCA
2
DNA repair
Breast
cancer(female
and male)
MSH2
DNA
Hereditary non-
Caretake
rs
Gene
Mutation permits
Two-hit
Hypothesis
Hereditar
y
Mutation
Nonhereditar
y
Mutation
Rb
Rb
Rb inactive
G1
G2
G1
S
M
G2
p53 Gene
Situated at the short arm of the chromosome 17
Mutated in most of the cancer cases
Normal functions p53
Repair of damaged DNA before S-phase in the
cycle by arresting the cell cycle in G1 until the
damage is repaired
Apoptotic cell death if there is extensive DNA
damage.
p53 Gene
P53 level raise in cells with sustained cell
damage, until the damage is repaired or
cell undergoes apoptosis
Prevents propagation of possibly mutated
cells
Called the guardian of the genome
p53 Gene
P53 can lose its function by:
Non-sense mutation or mis-sense
mutation
Complex of normal p53 and mutant
p53 inactivating the function of
normal allele
Binding of normal p53 to viral
Structure of p53
QuickTime and a
TIFF (Uncompressed) decompressor
are needed to see this picture.
Familial cancer
syndromes involving
DNA repair enzymes
Nucleotide excision repair (NER) genes:
Xeroderma pigmentosum
. In NER-deficient cells non-repaired
dimers
lead to missense mutations during DNA
replication
Activating oncogene mutations
Inactivating tumor suppressor gene mutations
Hereditary Non-Polyposis
Colon
Carcinoma
Autosomal dominant
inheritance
Penetrance ~80%
Genes belong to
DNA mismatch
repair (MMR) family
Tumor site in proximal
colon predominates
Extracolonic cancers:
endometrium, ovary,
stomach, urinary tract,
small bowel, bile ducts,
Normal DNA
repair
TCGAC
AGCTG
T C TA C
AGCTG
Defective DNA
repair (MMR+)
T C TA C
AGCTG
TC
TAC
AG
ATG
Microsatellite
instability
Addition of
nucleotide repeats
Contribution of Gene
Mutations
to HNPCC
Families
Sporadic
Familial
Unknown
~30%
Rare CRC
syndrom
es
FAP
MSH2
~30%
HNPCC
MSH6
(rare)
PMS1
(rare)
PMS2
(rare)
MLH1
~30%
Electrophoresis gel
MSI tumor
Li-Fraumeni syndrome
Refers to the inherited predisposition
to develop cancers in many organs
owing to germ line mutations of p53
Affected individuals Carry germ line
mutation in one p53 allele, but tumors
display mutation at both alleles
Another example of two-hit hypothesis
Other tumor
suppressor genes
APC Gene
Implicated in familial adenomatous polyposis
coli and most sporadic colorectal cancers
APC binds to and inhibits the function of
catenin
-catenin activates certain transcription factors
that activates several genes including myc and
cyclin D
Mutant APC is unable bind -catenin to down
regulate its activity
oncogene
Tumor suppressors
WT-1 gene
Is deleted in hereditary Wilms
tumor(WT)
It codes for a DNA-binding protein that
represses transcription of PDGF,IGF-I
and abl2, which promotes growth
Loss of WT-1 gene expression also
occur in many breast cancers
NF-1 gene
Germ line mutation in type 1
neurofibromatosis(NF)
Encode neurofibromin, a negative
regulator of ras
Inactivation of NF-1 permits
unopposed ras, thereby promotes cell
growth
PTEN gene
Termed phosphatase and tensin homologue
Mutated in most prostate cancers and many
glioma and thyroid cancers
The gene product suppresses tumor growth
by antagonising tyrosine kinases
Regulates invasion and metastasis
Germ line mutation responsible for Cowden
syndrome
Multiple hamartoma
Increased risk of cancers of the breast,
thyroid and endometrium
RET
RETis an abbreviation for "rearranged during transfection",
as theDNA sequenceof thisgenewas originally found to
be rearranged within afibroblastcell line following its
transfectionwith DNA taken from humanlymphomacells.
Gene on chromosome 10 q 11.2
Encodes a receptor tyrosine kinase
Required for maturation of nervous system and kidney
morphogenesis
Cys
Cys
GFR 1
Extracellular Domain
RET
GDNF
Cys
Cys
Cell Membrane
P
P
RAS-RAF Pathway
Intracellular Domain
RET Proto-Oncogene in
MEN Type 2
Germline point mutations of RET are
responsible for all Forms of MEN Type
2
The mutations affect either the
extracellular or the intracellular
tyrosine kinase domain of RET
receptor.
Cys
Cys
GFR 1
RET
Extracellular Domain
Arg
Cys
Cell Membrane
P
P
P
Intracellular Domain
Uncontrolled
Cell Proliferation
GENE Therapy
What is Gene
It is a technique for
Therapy
correcting defective
Why Viruses?
Lentiviruses
Poxviruses
Herpes Viruses
Adenovirus
Adenovirus
Introduction of the
foreign DNA into cell
by use liposome is
known as lipofection.
Introduction of DNA
into cell by exposing
a very brief period of
high voltage electric
Future of gene
therapy:
Can lead to the cure of most harmful
diseases like cancer, aids.
The efficient gene therapy method i.e. stem
cells gene therapy can control to heredity of
diseases.
May lead to a progress in Drug Designing.
Can Lead to cure of certain CNS(Central
Nervous
References
De Vita, Hellman and Rosenbergs
CANCER Principles and Practices of
Oncology, 8th Edition.
Schwartzs Principles of Surgery, 9th
Edition.
Sabiston textbook of Surgery, 18th
Edition.
Bailey and Loves Short Practice of
Surgery, 25th Edition.
Surgical Clinics of North America, Aug
2008.